The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 10 - Bracanalysis Cdx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bracanalysis Cdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bracanalysis Cdx Today - Breaking & Trending Today
Americans' anxiety impacted by the ongoing pandemic, yet 1
SALT LAKE CITY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they...
Source: globenewswire.com
Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
Share: SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced that it will present results from a study with more than 275,000 women validating the use of a new method for polygenic breast cancer risk assessments in women of all ancestries. The new data will be shared in an oral presentation with leading collaborators on June 4 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. "The polygenic risk score (PRS) is one of the most powerful risk prediction tools in the field ...
Source: benzinga.com
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune's Vectra Testing Business to Labcorp
Share: SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced that it has entered into a definitive agreement to sell select operating assets and intellectual property (IP), including the Vectra® test, from Myriad Autoimmune's business unit to Labcorp (NYSE:LH) for $150 million in cash. Labcorp is a leading global life sciences company and one of the nation's largest laboratory service providers. "Our agreement with Labcorp meets our goals of ensuring broad access to the Vectra® test for patients,...
Source: benzinga.com
Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment
SALT LAKE CITY, April 28, 2021 (GLOBE NEWSWIRE) -- In a new nationwide poll, the GeneSight ® Mental Health Monitor found that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment. “Depression is one of the most misunderstood disorders. When people misinterpret patients with depression as ‘lazy’ or ‘dramatic,’ they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive...
Source: marketscreener.com